|
NEWS, EVENTS, and DEADLINES
October 18, 2024
| |
Learning Health System Science Inaugural Cohort | |
|
We are thrilled to announce the inaugural Learning Health System Science Scholars cohort, part of the Learning Health System Scientist Training and Research Center of New Jersey (LHS STAR NJ).
LHS STAR NJ is a new program funded by the federal Agency for Healthcare Research and Quality, dedicated to training future scholars and healthcare professionals in health system science. Our program equips participants with the skills to identify and evaluate best practices and innovations to enhance the quality, safety, efficiency, equity, and outcomes of care delivered by our academic health system and partner organizations.
The inaugural cohort consists of 13 Learning Health System Scholars.
To learn more about LHS STAR NJ, visit https://sites.rutgers.edu/lhsstarnj/.
Shawna Hudson, PhD and Ethan Halm, MD, are the Co-PIs for the LHS STAR NJ program, as well as being Co-Lead for NJ ACTS Community and the K Scholars Program, respectively
| |
Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events | |
|
Princeton Precision Health
2024 Seminar Series
Princeton Precision Health is a cross-cutting initiative that uses AI and data science to transform human health at all levels, from molecular to social to environmental, with the goal of enacting smart policy and evidence-based clinical practice.
| |
|
Data-Driven Precision Health: Integrating Genomics, Climate, and the Environment
November 7, 2024
8 am - 5:30 pm
in person
Maeder Hall, Andlinger Center
86 Olden Street
Princeton University
| |  |
|
Talking tech: How parents and kids co-create social norms about technology use
Emily Foster-Hanson, PhD
Department of Psychology, Swarthmore College
November 15, 2024
12 pm - 1 pm
in person
252 Nassau Street
Princeton, NJ
| | |
|
Propelus I-Corps is a program designed for research teams with a technology innovation to explore how their discovery can help potential customers and meet industry needs as a startup or venture.
Propelus I-Corps hosted by Princeton University
| |
|
Online
January 8, 10, 17 and 24
9:30 am - 12:30 pm
Apply by Dec. 5
| | |
Princeton's Brooks, Gitai Win Prestigious NIH Awards
Every year, the National Institutes of Health selects a handful of researchers performing innovative blue-sky scientific research to receive funding through its High-Risk, High-Reward Research program. This year John F. Brooks II and Zemer Gitai were two of four Princeton University researchers to be named. Read the full article.
Dr. Brooks is a NJ ACTS TL1 Fellow's mentor. Dr. Gitai was a 2019 NJ ACTS Pilot Program awardee and a TL1 Mentor.
| |
|
Scar-Free Healing? A Parasitic Worm Could Be the Key
Scientists have long tried to find ways of safely boosting the ability to heal without causing scars. Researchers at Rutgers University, including William Gause, PhD, New Jersey Medical School, and at the University of Glasgow in Scotland have found a candidate, thanks to a parasitic roundworm known as Heligmosomoides polygyrus. The team’s findings were published this August in the journal Life Science Alliance. Read the Full article on Gizmodo
Dr. Gause was an NJ ACTS Pilot awardee in 2020 with Dr. Andrea Graham of Princeton University for their project titled "Improving mouse models of lung defense: neutrophil-mediated parasite resistance, tissue damage, and repair."
| |
NCATS, NIH, and Federal News and Events | |
Collaboration Webinars from the
Hear from CTSA TIN experts on trial-related topics to improve your project
| |
|
Adaptive Clinical Trial Designs: From Basics to Bayesian
As resources become increasingly limited, adaptive clinical trial designs have been proposed to conduct more efficient translational research. These designs include elements to stop trials before completion for futility, efficacy, or safety; adapt the allocation across study arms; enrich the population enrolled; revise target sample sizes; or to add/drop study arms.
November 20, 2024
12 pm
| |
|
NJ ACTS Publication Highlights
An item response theory analysis of the matrix reasoning item bank (MaRs-IB). Samuel Zorowitz, Gabriele Chierchia, Sarah-Jayne Blakemore, Nathaniel D Daw. Behavior Research Methods. 2023 Apr 5. doi: 10.3758/s13428-023-02067-8. Online ahead of print.
A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection. Amit Singla, Nicholas B Dadario, Ashima Singla, Patricia Greenberg, Rachel Yan, Anil Nanda, Detlev Boison, Rakesh Malhotra, Sunil Patel, Suri Nipun, Kaur Maninderpal, Dorothy Castro, Sanaa Bdiiwi, Hala Boktor, Htay Htay Kyi, Anne Sutherland, Amee Patrawalla, Kevin Ly, Yingda Xie, Ashish Sonig, Priyank Khandelwal, James Liu, Joseph Koziol, Diana Finkle, Sara Subanna, Steven K Libutti. Randomized Controlled Trial>PLoS One. 2023 Jan 30;18(1):e0274243.
| | |
|
Princeton University's Nassau Hall, home to the Office of the President and other senior administrators, served as the nation’s capital for four months and eight days in 1783, when it played host to meetings of the Continental Congress. | |
The Rutgers Equity Alliance for Community Health (REACH) Community-Academic Grants Program is designed to improve health outcomes in economically disadvantaged communities by addressing social determinants of health. Learn More and Apply by October 25, 2024. | |
The New Jersey Kids Study has just launched its pilot study to assess exposures that affect children's health. They hope to enroll pregnant people in their first trimester in this IRB-approved study. | |
NIH 2024 DataWorks! Prize. Rewarding new and innovative approaches to data sharing and reuse in research. View Website and Apply by October 23rd. Total cash prizes: $500,000 | |
NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
| |
|
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
Send story ideas to NJACTS@rbhs.rutgers.edu
UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019
| | | | |
